par Golstein, Sophie
;Muylle, Kristoff
;Vercruyssen, Marie
;Spilleboudt, Chloé
;de Wind, Alexandre;Bron, Dominique 
Référence European journal of haematology, 101, 3, page (415-417)
Publication Publié, 2018-09
;Muylle, Kristoff
;Vercruyssen, Marie
;Spilleboudt, Chloé
;de Wind, Alexandre;Bron, Dominique 
Référence European journal of haematology, 101, 3, page (415-417)
Publication Publié, 2018-09
Article révisé par les pairs
| Titre: |
|
| Auteur: | Golstein, Sophie; Muylle, Kristoff; Vercruyssen, Marie; Spilleboudt, Chloé; de Wind, Alexandre; Bron, Dominique |
| Informations sur la publication: | European journal of haematology, 101, 3, page (415-417) |
| Statut de publication: | Publié, 2018-09 |
| Sujet CREF: | Hématologie |
| Mots-clés: | 90Y-rituximab |
| nodular lymphocyte-predominant Hodgkin lymphoma | |
| radioimmunotherapy | |
| salvage treatment | |
| MeSH keywords: | Adult |
| Biopsy | |
| Follow-Up Studies | |
| Hodgkin Disease -- diagnosis -- mortality -- therapy | |
| Humans | |
| Immunohistochemistry | |
| Lymphocytes -- pathology | |
| Male | |
| Positron Emission Tomography Computed Tomography | |
| Radioimmunotherapy | |
| Recurrence | |
| Rituximab -- therapeutic use | |
| Tomography, X-Ray Computed | |
| Treatment Outcome | |
| Yttrium Radioisotopes -- therapeutic use | |
| Note générale: | SCOPUS: ar.j |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0902-4441 |
| info:doi/10.1111/ejh.13087 | |
| info:scp/85050794667 | |
| info:pmid/29719928 |



